Skip to main content
Official Logo of Columbia Business School
Academics
  • Visit Academics
  • Degree Programs
  • Admissions
  • Tuition & Financial Aid
  • Campus Life
  • Career Management
Faculty & Research
  • Visit Faculty & Research
  • Academic Divisions
  • Search the Directory
  • Research
  • Faculty Resources
  • Teaching Excellence
Executive Education
  • Visit Executive Education
  • For Organizations
  • For Individuals
  • Program Finder
  • Online Programs
  • Certificates
About Us
  • Visit About Us
  • CBS Directory
  • Events Calendar
  • Leadership
  • Our History
  • The CBS Experience
  • Newsroom
Alumni
  • Visit Alumni
  • Update Your Information
  • Lifetime Network
  • Alumni Benefits
  • Alumni Career Management
  • Women's Circle
  • Alumni Clubs
Insights
  • Visit Insights
  • Digital Future
  • Climate
  • Business & Society
  • Entrepreneurship
  • 21st Century Finance
  • Magazine

Evolving Ethics and the Covid Pandemic

Angela Rossetti ’80, a guest lecturer at Columbia’s Vagelos College of Physicians and Surgeons, brings to light businesses’ evolving ethical compass by comparing the dishonorable business decisions of the 1918 flu pandemic with the collaborative, moral commitments made by today’s business leaders in the time of Coronavirus.

Published
May 18, 2020
Publication
Bernstein Center for Leadership and Ethics
Jump to main content
Article Author(s)

Angela Rossetti ’80

Affiliated Author
Covid-19 cell
Category
Thought Leadership
News Type(s)
Leadership and Ethics News
Topic(s)
Ethics and Leadership, Healthcare

0%

In 1895, H.G. Wells imaginatively traveled into the future in a time machine. In that future, he found two classes of humans—angry underground workers and an above-ground leisure class without ambition, energy or leadership. Business as an integral, ethical part of society simply did not exist.   

Twenty-three years later, a flu pandemic emerged just as business was becoming the engine of American prosperity—millions of Americans had already crowded into cities to earn a better living in factories than they could on farms. When the flu hit New York in 1918 theatres and businesses did not initially close. Saloons were still serving in Providence, department stores and restaurants were open in Philadelphia, and sporting events drew big crowds. In September of 1918, Babe Ruth appeared in Connecticut to support the troops who were still slugging it out in WWI and drew 5,000 fans. Just three days later, the state health department issued a second warning about the flu. By October, there were more than 33,000 cases in Connecticut alone, spurred in part by business-sanctioned public gatherings. Physicians and nurses were largely alone in the fight, astounded by the fast and deadly spread of the disease. On the other hand, business leaders were notably absent. 

More than a century later, the Covid-19 pandemic rolls around the globe like a tsunami, however the corporate scene is drastically different. Doctors and nurses are not alone as business leaders harmonize with science and sociology to stop the spread. GM and Ford are making respirators, liquor distillers are producing hand sanitizer, Ivy League clothiers are creating fashionable masks, and retired executives are helping to find a vaccine. "Doctors and nurses are not alone as business leaders harmonize with science and sociology to stop the spread." Indra Nooyi, former CEO of Pepsi, is leading a multi-disciplinary task force comprised of an epidemiologist, a bioethicist, and a former FDA commissioner in order to get the quarantined masses out of lockdown and back to work.   

The 1918 influenza pandemic killed 50 million people. Covid-19 will likely kill far fewer, in part because of the responsiveness of clear-headed, ethical business leaders working collaboratively with government and healthcare sectors. By acting ethically, today’s business leaders may help change the trajectory of this deadly killer, and in doing so, they are lightyears ahead of their early 20th century counterparts. H.G. Wells would be impressed.

Angela Rossetti is a former Vice President of Global Commercial Development at Pfizer and a consultant to the biopharmaceutical industry. She is currently an Adjunct Assistant Professor of Pharmaceutical and Medical Ethics at New York Medical College and a guest lecturer at Columbia Vagelos College of Physicians and Surgeons.

Save Article

Download PDF

Share
  • Share on Facebook
  • Share on Threads
  • Share on LinkedIn

External CSS

Official Logo of Columbia Business School

Columbia University in the City of New York
665 West 130th Street, New York, NY 10027
Tel. 212-854-1100

Maps and Directions
    • Centers & Programs
    • Current Students
    • Corporate
    • Directory
    • Support Us
    • Recruiters & Partners
    • Faculty & Staff
    • Newsroom
    • Careers
    • Contact Us
    • Accessibility
    • Privacy & Policy Statements
Back to Top Upward arrow
TOP

© Columbia University

  • X
  • Instagram
  • Facebook
  • YouTube
  • LinkedIn